학술논문

Systemic drug-related intertriginous and flexural exanthema-like eruption after Oxford-AstraZeneca COVID-19 vaccine.
Document Type
Letter
Source
Clinical & Molecular Allergy. 12/12/2022, Vol. 20 Issue 1, p1-5. 5p.
Subject
*SKIN diseases
*COVID-19 vaccines
*EXANTHEMA
*COVID-19 pandemic
Language
ISSN
1476-7961
Abstract
Systemic drug-related intertriginous and flexural exanthema (SDRIFE) is an adverse drug reaction which manifests as a symmetrical erythematous rash involving the skin folds after systemic drug exposure. A vast array of possible side effects associated with administration of different anti-SARS-CoV-2 vaccines have been reported in literature since the beginning of the COVID-19 pandemic, but only few times SDRIFE-like eruptions have been described in this context. We discuss here a case of SDRIFE-like eruption following the second dose of Oxford-Astrazeneca Vaxzevria vaccine. [ABSTRACT FROM AUTHOR]